255 related articles for article (PubMed ID: 19553339)
1. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.
Liu Q; Sun Y; Rihn S; Nolting A; Tsoukas PN; Jost S; Cohen K; Walker B; Alter G
J Virol; 2009 Sep; 83(17):8705-12. PubMed ID: 19553339
[TBL] [Abstract][Full Text] [Related]
2. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
[TBL] [Abstract][Full Text] [Related]
3. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
[TBL] [Abstract][Full Text] [Related]
4. Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection.
He X; Li D; Luo Z; Liang H; Peng H; Zhao Y; Wang N; Liu D; Qin C; Wei Q; Yan H; Shao Y
PLoS One; 2013; 8(2):e56309. PubMed ID: 23424655
[TBL] [Abstract][Full Text] [Related]
5. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
Tang CC; Isitman G; Bruneau J; Tremblay C; Bernard NF; Kent SJ; Parsons MS
Clin Exp Immunol; 2015 Aug; 181(2):275-85. PubMed ID: 25644502
[TBL] [Abstract][Full Text] [Related]
6. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).
Bhatnagar N; Ahmad F; Hong HS; Eberhard J; Lu IN; Ballmaier M; Schmidt RE; Jacobs R; Meyer-Olson D
Eur J Immunol; 2014 Nov; 44(11):3368-79. PubMed ID: 25100508
[TBL] [Abstract][Full Text] [Related]
7. Deficient IL-2 Produced by Activated CD56
Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
Front Immunol; 2019; 10():1647. PubMed ID: 31379845
[No Abstract] [Full Text] [Related]
8. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression.
Parsons MS; Tang CC; Jegaskanda S; Center RJ; Brooks AG; Stratov I; Kent SJ
J Immunol; 2014 Jan; 192(1):308-15. PubMed ID: 24319263
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
10. Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions.
Kristensen AB; Kent SJ; Parsons MS
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514913
[TBL] [Abstract][Full Text] [Related]
11. Positive correlation between the natural killer and gp 120/41-specific antibody-dependent cellular cytotoxic effector functions in HIV-infected individuals.
Ahmad A; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):115-9. PubMed ID: 7552474
[TBL] [Abstract][Full Text] [Related]
12. HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
Jensen SS; Fomsgaard A; Borggren M; Tingstedt JL; Gerstoft J; Kronborg G; Rasmussen LD; Pedersen C; Karlsson I
PLoS One; 2015; 10(12):e0145249. PubMed ID: 26696395
[TBL] [Abstract][Full Text] [Related]
13. A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity.
Klein JS; Webster A; Gnanapragasam PN; Galimidi RP; Bjorkman PJ
AIDS; 2010 Jul; 24(11):1633-40. PubMed ID: 20597163
[TBL] [Abstract][Full Text] [Related]
14. The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection.
Chen X; Lin M; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Dong T; Shang H; Jiang Y
Front Immunol; 2018; 9():2322. PubMed ID: 30356637
[TBL] [Abstract][Full Text] [Related]
15. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.
Parsons MS; Richard J; Lee WS; Vanderven H; Grant MD; Finzi A; Kent SJ
AIDS Res Hum Retroviruses; 2016; 32(10-11):1089-1096. PubMed ID: 27487965
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
Loubeau M; Ahmad A; Toma E; Menezes J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
[TBL] [Abstract][Full Text] [Related]
17. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
Front Immunol; 2019; 10():2741. PubMed ID: 31827470
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
[TBL] [Abstract][Full Text] [Related]
20. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]